AI assistant
Imunon, Inc. — Director's Dealing 2014
Jun 24, 2014
35124_dirs_2014-06-24_77bb179b-2ecb-4d0b-a31e-7d379e37abc7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2014-06-20
Reporting Person: Anwer Khursheed (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-20 | Celsion Corporation Common Stock | A | 5000 | $3.50 | Acquired | 5000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-20 | Option to Purchase Celsion Corporation Common Stock | $3.50 | A | 40000 | Acquired | 2024-06-20 | Celsion Corporation Common Stock (40000) | Direct |
| 2014-06-20 | Restricted Stock Award | $3.50 | A | 35000 | Acquired | 2017-06-30 | Ceslion Corporation Common Stock (35000) | Direct |
Footnotes
F1: The Officer was provided a stock grant on June 20, 2014
F2: Represents the per share fair value of the common stock grant based on the closing price of Celsion Corporation Common Stock on the date of grant.
F3: 10,000 options vested immediately and the remaining options vest in quarters on June 20, 2015, June 20, 2016, June 20, 2017 and June 20, 2018.
F4: The restricted share award of Celsion Corporation Common Stock vests in one installment on the third anniversary of the officer's starting date subject to continued employment through that vesting date.